GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yungjin Pharm Co Ltd (XKRX:003520) » Definitions » EV-to-Revenue

Yungjin Pharm Co (XKRX:003520) EV-to-Revenue : 1.86 (As of Apr. 27, 2024)


View and export this data going back to 1973. Start your Free Trial

What is Yungjin Pharm Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Yungjin Pharm Co's enterprise value is ₩437,091 Mil. Yungjin Pharm Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩234,902 Mil. Therefore, Yungjin Pharm Co's EV-to-Revenue for today is 1.86.

The historical rank and industry rank for Yungjin Pharm Co's EV-to-Revenue or its related term are showing as below:

XKRX:003520' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.55   Med: 4.33   Max: 16.76
Current: 1.86

During the past 13 years, the highest EV-to-Revenue of Yungjin Pharm Co was 16.76. The lowest was 1.55. And the median was 4.33.

XKRX:003520's EV-to-Revenue is ranked better than
59.26% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs XKRX:003520: 1.86

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-27), Yungjin Pharm Co's stock price is ₩2080.00. Yungjin Pharm Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩1,272.08. Therefore, Yungjin Pharm Co's PS Ratio for today is 1.64.


Yungjin Pharm Co EV-to-Revenue Historical Data

The historical data trend for Yungjin Pharm Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yungjin Pharm Co EV-to-Revenue Chart

Yungjin Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.56 7.09 5.00 2.90 1.90

Yungjin Pharm Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.90 2.64 2.20 2.07 1.90

Competitive Comparison of Yungjin Pharm Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Yungjin Pharm Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yungjin Pharm Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yungjin Pharm Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Yungjin Pharm Co's EV-to-Revenue falls into.



Yungjin Pharm Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Yungjin Pharm Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=437090.639/234902.46
=1.86

Yungjin Pharm Co's current Enterprise Value is ₩437,091 Mil.
Yungjin Pharm Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩234,902 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yungjin Pharm Co  (XKRX:003520) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Yungjin Pharm Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2080.00/1272.078
=1.64

Yungjin Pharm Co's share price for today is ₩2080.00.
Yungjin Pharm Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,272.08.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yungjin Pharm Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Yungjin Pharm Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Yungjin Pharm Co (XKRX:003520) Business Description

Traded in Other Exchanges
N/A
Address
Olympic-ro 35da-gil, Songpa-gu, (7-16, Shincheon-dong), 13, Seoul, KOR, 134-020
Yungjin Pharm Co Ltd is a Korean pharmaceutical company. It manufactures and sales pharmaceutical goods in domestic and overseas markets. The firm's products are cephalosporin antibiotic, antipsychotic, cardiovascular, total nutrition, etc. It has manufacturing facilities located in Jenjou, Namyang, and Iksan in Korea.

Yungjin Pharm Co (XKRX:003520) Headlines

No Headlines